Skip to Main Content

On April 22, 2024, UnitedHealth Group issued a press release, providing an update on the Change Healthcare cybersecurity incident that occurred on Feb. 21, 2024. Given the size of the data impacted, the investigation to determine whose data is impacted is expected to take several months. UnitedHealth Group believes this situation will impact “a substantial proportion of people in America” and is offering immediate credit monitoring and identity protection services, as well as a dedicated contact center to address questions. Visit Change Healthcare Cyberattack Support and/or reach out to the contact center at 1-866-262-5342 regarding any questions.

Oncology Codes with new PA Requirements

Date: 10/25/17

November 1, 2017

The following drugs have changes to authorization requirements for all providers effective January 1, 2018. These changes apply to Managed Health Services (MHS) members enrolled in Hoosier Care Connect, Hoosier Healthwise, the Healthy Indiana Plan (HIP) and Ambetter plans.

Oncology Codes:

Currently the following drugs do not require authorization for hospitals, hematologists, oncologists, and neurologists. Effective January 1, 2018 the codes below will require prior authorization for all providers.  This change is being implemented to ensure these drugs are being utilized according to NCCN (National Comprehensive Cancer Network®) guidelines. Requests for these drugs will be reviewed using our previously established medical necessity criteria.

  • Adcetris (brentuximab) -  J9042
  • Keytruda (pembrolizumab) – J9271
  • Opdivo (nivolumab) – J9299

Please visit mhsindiana.com for more information on how to submit prior authorization or to check prior authorization requirements for other services.



Last Updated: 10/26/2017